María Cristina Gingerich

机构：Georgia College & State University, University of Georgia

发表论文 11 篇 · 总被引 81 次 · h-index 5

代表论文

• Intranasal parainfluenza virus type 5 (PIV5)–vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study (2023 · Science Advances · 被引 38)
• Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year (2024 · npj Vaccines · 被引 15)
• Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)–vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial (2025 · Science Advances · 被引 11)
• Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants (2025 · Journal of Virology · 被引 8)
• A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates (2025 · Journal of Virology · 被引 7)
• Modified OspA Delivered Via Distinct Vehicles and Routes Confers Equivalent Protection Against Tick-Transmitted Borrelia burgdorferi (2026 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)